What is Chemical Works of Gedeon Richter FCF Yield %?
Chemical Works of Gedeon RichterRGEDF -1.78%94 FCF Yield % is 4.62 as of Jun. 27, 2026, which is 12% above its 10-year median of 4.11. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.22 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 70.85% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Chemical Works of Gedeon Richter FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Chemical Works of Gedeon Richter FCF Yield % Related Terms
Chemical Works of Gedeon Richter FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemical Works of Gedeon Richter FCF Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemical Works of Gedeon Richter FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Chemical Works of Gedeon Richter's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemical Works of Gedeon Richter (RGEDF) has a FCF Yield % of 4.62 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Chemical Works of Gedeon Richter and its competitors. This is 12% above median its historical median of 4.11. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #293 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 29.2%.
Is Chemical Works of Gedeon Richter's FCF Yield % too high?
Chemical Works of Gedeon Richter's current FCF Yield % of 4.62 is 12% above median its 10-year median of 4.11. The Drug Manufacturers industry median FCF Yield % is 0.67. Chemical Works of Gedeon Richter's value of 4.62 is 589.6% above this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #293 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #293 out of 1005 companies for FCF Yield %. This puts Chemical Works of Gedeon Richter in the upper half of its industry. The industry median FCF Yield % is 0.67. Chemical Works of Gedeon Richter's value of 4.62 is 589.6% above this benchmark. While the company's 10-year median is 4.11 vs. the industry median of 0.67, Chemical Works of Gedeon Richter has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current FCF Yield % of 4.62 is 589.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current FCF Yield % is 4.62, which is 12% above median its own 10-year median of 4.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.22, compared to a current price of $39.59 — trading 12.4% above its estimated fair value. The current FCF Yield % is 4.62, which is 12% above median its 10-year median of 4.11 and 589.6% above the Drug Manufacturers industry median of 0.67. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current FCF Yield % is 4.62 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued.
The current stock price of $39.59 is trading 12.4% above its estimated GF Value™ of $35.22.
GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.
Key valuation signals for RGEDF:
FCF Yield %: 4.62 (12% above median its 10-year median of 4.11)
GF Value™: $35.22 vs. price of $39.59 (12.4% above fair value)
Industry Position: 589.6% above the Drug Manufacturers median (#293 of 1005)
No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemical Works of Gedeon Richter Business Description
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score
Get the complete analysis for RGEDF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGEDF has been successfully added to your 
